XWELL (NASDAQ:XWEL) Announces Earnings Results

XWELL (NASDAQ:XWEL) issued its earnings results on Wednesday. The company reported ($1.51) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.00) by ($0.51), Zacks reports. XWELL had a negative return on equity of 352.37% and a negative net margin of 58.17%.

XWELL Price Performance

Shares of XWEL remained flat at $1.46 on Wednesday. 48,470 shares of the company were exchanged, compared to its average volume of 5,649,626. The stock has a market capitalization of $11.58 million, a PE ratio of -0.29 and a beta of 1.01. The company’s 50-day moving average price is $1.28 and its 200 day moving average price is $0.88. XWELL has a one year low of $0.26 and a one year high of $2.20.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Wall Street Zen cut XWELL from a “hold” rating to a “sell” rating in a report on Sunday. Weiss Ratings cut XWELL from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 13th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.